| Why carry out this study? |
| The clinical efficacy of intravitreously administered Conbercept (IVC) has been reported in some prospective and retrospective studies to date. However, the evidence on efficacy of IVC monotherapy for DME was still limited |
| What was the evidence-based efficacy of IVC monotherapy for DME? |
| What was learned from the study? |
| Our findings suggest improved VA and CMT outcomes during 1-year follow-up in patients with DME who underwent IVC monotherapy |
| Increased injection frequency demonstrates a significant trend with improved outcomes at 12 months |
| IVC monotherapy as the initial treatment might be a treatment option for DME |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.